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A B S T R A C T
A lactonic steroid with an unprecedented 1, 10: 8, 9-disecoergostane framework was identified from the ethyl
acetate-methanol extract of buccinid gastropod mollusk, Babylonia spirata collected from the southwestern coast
of Indian peninsular region. The compound was characterized as 1, 10: 8, 9-disecoergosta-8-en-A-homo-6a-oxa-
1-one by exhaustive spectroscopic methods including two-dimensional nuclear magnetic resonance and mass
spectroscopic investigations. The disecosteroid displayed moderate carbolytic enzyme inhibition activity as
distinguished by its inhibitive effects against α-amylase and α-glucosidase (IC50 0.40 and 0.54mg/mL, respec-
tively). The anti-inflammatory (5-lipoxidase inhibitory) activity of the titled secondary metabolite was found to
be superior (IC50 < 0.85mg/mL) than the commercial anti-inflammatory drug (ibuprofen IC50 > 0.85mg/
mL). However, significantly greater antioxidant property was recorded for the studied disecosteroid as evaluated
by in vitro 2, 2-diphenyl-1-picrylhydrazyl radical inhibition potential (IC50 0.30mg/mL) than that of standard, α-
tocopherol (IC50 > 0.50mg/mL). The in silico molecular docking studies were conducted to explain the anti-5-
lipoxidase and anti-α-amylase properties of the isolated compound. The molecular binding interactions of the
ligands with the pro-inflammatory 5-lipoxidase and the carbolytic enzyme α-amylase, demonstrated that their
binding energies/docking scores were positively associated with their in vitro bioactivities. A plausible pathway
for the biosynthetic origin of lactonic disecosteroid in B. spirata was proposed from an ergosterol precursor.
Structure-activity correlation study demonstrated that the biological activities of the disecosteroid were directly
proportional to their electronic properties allied with lesser steric restrictions.
1. Introduction
Steroidal molecules comprise a very significant class of natural
products owing to their capability to cross the lipophilic membrane of
the cell, and after binding to the steroid receptors, articulate their de-
tailed physiological functions [1]. Marine invertebrates have been a
major source of unusual sterols with variations in the side chain and
nucleus [2]. Structural modifications of the steroid nucleus from marine
organisms were found to comprise of seco and nor-steroids, which have
no terrestrial analogues [3]. Secosteroids are intermediary products of
metabolic reactions that occur within the cell of the organism resulting
in the severance of the bonds within the rings of the tetracyclic steroid
nucleus. The scission of the 5,6-, 8,9-, 8,14-, 9,10-, 9, 11-, 1, 10, and 13,
17- bonds were observed in the reported marine secosteroids, and they
have formed several principal factions based on their chemical struc-
tures [3,4]. The secosteroids are evolving as a potential class of new
molecular structures and the importance of these classes of organic
compounds have been emphasized by biological activities, such as anti-
proliferative, anti-fouling, anti-inflammatory, anti-microbial and anti-
oxidant [4–6]. The epoxy-5, 10: 8, 9-disecoergosta-diene-dione was
reported from a fungus, Sporormiella irregularis [7]. The lactonic 1, 10-
secoergostane compound was reported from a marine soft coral, Cla-
vularia viridis [8]. Till date, the stratagem of biogenics of these unusual
steroids and their biological functions were not fully known [4].
However, it was hypothesized that the biochemical modification of the
dietary sterols or innate steroidal components within the body of the
organism might occur as a result of body’s chemical defense reaction to
external stimulus, or as a result of symbiotic relationship between
various organisms [9].
Gastropods are benthic marine invertebrates, which were estab-
lished to contain steroids with diverse biological potentials [10,11]. In
pursuit of unprecedented pharmacophore leads, we chose to investigate
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Babylonia spirata, which is an understudied marine gastropod species
with respect to their secondary metabolite chemistry. However, there
exist previous reports on their biological activities [12,13]. This is the
first report of a lactonic disecosteroid from the buccinid gastropod B.
spirata, and its pharmacological properties with respect to antioxidant,
carbolytic enzyme inhibition activity, and anti-inflammatory potentials.
Comprehensive nuclear magnetic resonance (NMR) techniques en-
circling DEPT analysis (distortionless enhancement by polarization
transfer), 1H-1H COSY (homonuclear correlation spectroscopy), HSQC
(heteronuclear single-quantum correlation), HMBC (heteronuclear
multiple bond correlation), and nuclear overhauser effect (NOE) spec-
troscopy experiments in conjugation with mass analyses were utilized
in the elucidation of the titled structure. The isolated secondary meta-
bolite was checked for its antioxidative {2, 2-diphenyl-1-picrylhydrazyl
(DPPH)/2, 2′-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid)
(ABTS+) radical scavenging}, carbolytic enzyme inhibition activity (α-
amylase/α-glucosidase inhibition) and anti-inflammatory {5-lipoxidase
(5-LOX) inhibition} properties through various in vitro investigations.
Structure-bioactivity correlation analyses were performed using the
various molecular descriptor variables calculated for the studied com-
pound. The in silico modes of α-amylase and 5-LOX enzyme inhibitions
by the lactonic disecosteroid were assessed by the molecular docking
models to correlate with it’s in vitro carbolytic enzyme inhibition and
anti-inflammatory activities, respectively.
2. Materials and methods
2.1. Chemicals and instrumentation
The spectroscopic/chromatographic/analytical quality reagents and
solvents were procured from E-Merck (Darmstadt, Germany). The
spectrophotometric analyses were attained on Varian Cary 50 conc
UV–visible spectrophotometer (Varian Cary, USA). A Perkin-Elmer
Series 400 FTIR spectrophotometer assembled with air cooled deuter-
ated triglycine sulfate detector scanning between 4000 and 400 cm−1
were used to record the Fourier-transform IR spectrum. Optical rota-
tions were calculated using ATAGO AP-300 polarimeter. The one-di-
mensional and two-dimensional NMR-spectral experiments were mea-
sured on Bruker AVANCE DPX 500 (500MHz) spectrometer, using
deuterated chloroform (CDCl3) as the aprotic solvent with tetra-
methylsilane (TMS) as internal reference. Chemical shifts (δ) were ex-
pressed in ppm and coupling constants in Hz. Electronic impact (EI)
mass spectrum was recorded on a gas chromatograph mass spectro-
meter instrument (GC–MS) (Perkin-Elmer Clarus 680 GC–MS fitted with
Elite 5 MS non-polar) fitted with a bonded phase capillary column
(50m X 0.22mm i.d. X 0.25 μm film thicknesses). Silica gel adsorbents
(60–120 mesh, E-Merck, Germany; 230–400 mesh, Biotage, Sweden)
were utilized for a range of column chromatography and pre-coated
plates of GF254 were used for thin layer chromatographic (TLC) se-
paration. Analytical high pressure liquid chromatograph (HPLC;
Shimadzu Corporation, Nakagyo-ku, Japan) connected to RP-C18 (Luna
250×4.6mm, 5 µm; bonded octadecylsilane reverse-phase;
Phenomenex, Torrance, USA) fitted to binary gradient pump (Shimadzu
LC-20AD) and photodiode array detector (SPD-M20A, Kyoto, Japan)
confirmed the purity of the studied compound.
2.2. Biological material collection and extraction
Specimens of the marine gastropod, B. spirata (Family Babylonidae)
were freshly collected from the Neendakara area of Kollam (Kerala
State of India) situated between the south-west coast of Indian penin-
sular (latitude 8°56′ North and longitude 76°32′ East). The voucher
specimen at CMFRI with accession number of DB.24.1.1. was recorded
as the reference for identification of the sample. The live samples were
immediately transported to the laboratory where the edible parts were
carefully removed from the shells, cleaned with tap water to wash off
the associated debris, and the tissues (5 kg) were minced to homo-
geneity. The minced tissues were lyophilized and powdered (1.5 kg)
before being sonicated with ethyl acetate-methanol solvent system
(EtOAc:MeOH 1:1 v/v, 500mL X 2, RT, 8 h). The contents were refluxed
at 50–60 °C for a period of 4 h, and the pooled fractions were sieved
using Whatman No. 1 before being desiccated using anhydrous Na2SO4
(40 g). The clarified filtrate (crude solvent extracts) were evaporated
(45 °C) to dryness using a rotavapor (Heidolph Instruments GmbH and
Co., Schwabach, Germany) operated under reduced pressure to afford a
brown-yellowish residue of crude EtOAc:MeOH extract of B. spirata.
The extraction processes were repeated thrice, and triplicate values
were calculated to estimate the yield (18 ± 0.50 g/kg, yield on dry
weight basis 1.8 ± 0.08%).
2.3. Isolation and spectroscopic analyses
The solvent extracts (50 g) of B. spirata obtained from EtOAc:MeOH
(1:1 v/v) mixture was chromatographed over silica gel of mesh sized
60–120 (100 g) loaded on to a glass column (5 cm X 150 cm). After in-
itial elution of the loaded chromatographic column using 100% n-
hexane (100mL) to eliminate the waxy and pigmented substances, the
solvent polarity was progressively increased using n-hexane-EtOAc,
100% EtOAc, and thereafter to EtOAc-MeOH, until 100% MeOH was
used. Fractions of 100mL were collected from time to time and their
TLC patterns were monitored. Fractions with similar TLC patterns were
pooled to obtain 6 major fractions SB1 through SB6, which were sub-
jected to bioactivity screening by selective antioxidant assays, such as
DPPH and ABTS+ radical decolorization, along with the inhibitory
activities against pro-inflammatory 5-LOX and carbolytic enzymes, α-
amylase/α-glucosidase. The key fraction, SB2 (50.0 mg) exhibited
greater bioactivities against the afore-mentioned markers, and there-
fore, was fractionated by flash chromatography (Biotage, 230–400
mesh, 12 g; Sweden, Biotage No. 25+M 0489–1) at UV collection
wavelength of 258 nm using n-hexane/EtOAc mixtures of rising polarity
to afford 14 fractions (50mL each). Out of 14 fractions (SB2-1-SB2-14),
the sub-fraction SB2-10 exhibited greater bioactive potencies against
DPPH/ABTS+ along with potential 5-LOX and α-amylase/α-glucosidase
inhibitory activities. Therefore, SB2-10 was subjected to a reverse-phase
octadecylsilane (RPC18) HPLC chromatographic purifications using
MeOH/acetonitrile (MeCN) (4:1 v/v) mixtures to give rise to the pure
compound (Rt 3.06min, 35mg). The studied compound was tested for
its homogeneity using TLC {n-hexane:EtOAc (3:7, v/v)} and RPC18
HPLC (MeOH/MeCN, 4:1) methodologies.
2.3.1. 1, 10: 8, 9-Disecoergosta-8-en-A-homo-6a-oxa-1-one
White amorphous solid; [α]26D −19.0°(CHCl3, c0.014); m.p.
125–127 °C (decom.); UV (MeOH) λmax (log ε 3.87): 210 nm; TLC (Si gel
GF254 2.0 cm; EtOAc:n-hexane, 7:3, v/v) Rf: 0.39; Rt (RPC18 HPLC,
MeOH:MeCN, 4:1, v/v): 3.06min; IR (cm−1) (stretching ν, bending δ,
rocking ρ): 2924, 2854 (C-Hν), 1745 (C=Oν), 1456 (C-Hδ), 1378 (C-
Hρ), 1072 (C-Oν), 843 (=C-Hδ), 742 (C-Hδ); 1H (CDCl3, 500MHz,
ppm), 13C (CDCl3, 125MHz, ppm), COSY and HMBC data were given in
Table 1; EIMS (electron impact mass spectrometry): found m/z
416.3658 [M]+, calculated for C28H48O2, 416.3654 (Δ=0.96 ppm).
2.4. Carbolytic enzyme inhibitory, anti-inflammatory and antioxidant
activities
Carbolytic enzyme inhibition activity of the studied lactonic dis-
ecosteroid was evaluated by the inhibitory properties against α-amylase
(from porcine pancreas) and α-glucosidase (from yeast) enzymes [14].
Inhibition of pro-inflammatory enzymes was calculated by the inhibi-
tion of 5-LOX [15] enzyme. The antioxidative activities were assessed
by DPPH [16], ferrous ion chelating (Fe2+ chelation) ability [16] and
ABTS+ [17] radical inhibition assays. The results were expressed as
IC50 (the concentration of samples at which 50% of enzyme/radical
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activities were inhibited/scavenged), which were expressed in mg/mL
values. Different physico-chemical parameters like steric {parachor
(Pr), molar volume (MV), molar refractivity (MR)}, and electronic
{polarizability (Pl)} factors were acquired by ChemDraw ultra 11 (8.0
database) and ACD Chemsketch (version 8.0) to describe the structure
activity relationship.
2.5. In silico molecular modeling
Molecular docking of disecosteroid was performed through the
software AutoDock 4 (AutoDock Tools version1.5.6). The titled com-
pound drawn through the ChemSketch (Freeware) 2016.2.2 (Advanced
Chemistry Development, Inc. Toronto, Canada) software was converted
to MDL Molfiles (V2000) and then to PDB format using OpenBabel GUI
2.4.1. The X-ray crystal structures of 5-lipoxidase (PDB ID 1N8Q; re-
solution 2.1 Å) [18] and α-amylase (PDB ID 1B2Y; resolution 3.2 Å)
[19] were obtained from the Protein Data Bank (www.pdb.org) before
being energetically minimized by the software, Swiss-PdbViewer
(SPDBV version 4.1.0). All ligands, cofactors and water were removed
in Autodock and macromolecules were assigned for polar hydrogens,
Kollman charges and atomic solvation. The grid box values were se-
lected as x= 15.174, y= 0.838, z= 18.996 (60 Å X 58 Å X 64 Å) for 5-
lipoxidase and x= 17.989, y= 21.315, z= 49.322 (56 Å X 54 Å X
62 Å) for α-amylase by Auto Grid algorithm. The docking studies were
carried out using Genetic and Lamarckian genetic algorithms methods.
Cygwin-I and Cygwin-II tools were used for performing the docking
algorithm. Thereafter, RMSD (Root-Mean-Square Deviation of atomic
positions) results were analyzed and the docked conformations calcu-
lated for their binding energies and docking scores. The USCF Chimera
1.11.2 software was used to analyze the molecular docking interactions
and visualizations.
2.6. Statistical studies
Statistical Program for Social Sciences 13.0 (SPSS, USA, ver. 13.0)
was used to develop the one way analysis of variance, which was used
to access the significant differences among the means of triplicates. The
results were presented as mean ± standard deviation of all sample
assays, and the significance of variances was presented as p < 0.05.
3. Results and discussion
3.1. Extraction and bioactivity-guided chromatographic fractionation
Initial bioactivity-assisted fractionation of EtOAc:MeOH (1:1, v/v)
extract of B. spirata over silica gel column resulted in various fractions,
as detailed in the materials section. It was noted that the fraction SB2
obtained at the solvent eluent gradient of EtOAc:n-hexane of 1:9 (v/v)
displayed greater antioxidative and 5-lipoxidase inhibition activities
(IC50 DPPH scavenging 0.65mg/mL; IC50 5-LOX inhibition 0.98mg/
mL) along with potential α-amylase/α-glucosidase inhibitory properties
(IC50 0.65–0.67mg/mL) than those recorded with other fractions
(IC50 > 1mg/mL). The column fraction SB2-10 obtained at the solvent
eluent gradient of EtOAc:n-hexane of 2:3 (v/v) after flash chromato-
graphic separation displayed greater antioxidative activities (IC50 DPPH
scavenging 0.48mg/mL) along with the inhibitory activities against
pro-inflammatory 5-LOX (IC50 0.91mg/mL) and carbolytic enzymes α-
amylase/α-glucosidase (IC50 0.48–0.57mg/mL) than those recorded
with other fractions (IC50 > 1mg/mL). Therefore, SB2-10 was used for
downstream preparative HPLC (MeOH/MeCN, 4:1 v/v) fractionation to
yield the studied compound.
3.2. Spectroscopic analyses
The degraded steroid, named as 1, 10: 8, 9-disecoergosta-8-en-A-
homo-6a-oxa-1-one was isolated as white amorphous solid upon re-
petitive chromatographic purifications. The molecular ion peak ob-
served at m/z 416 along with extensive spectroscopic analyses sug-
gested its molecular formula as C28H48O2. The double bond
equivalencies were deduced as five, which were found to incorporate
two unsaturations and three ring skeletons. The 13C NMR specified the
occurrences of 28 carbon signals. The DEPT spectrum together with 1H
and 13C were found to exhibit peaks due to eight methines, eleven
methylenes and six methyl carbon atoms, whereas the remaining sig-
nals were attributable to the quaternary carbon atoms. The six methyl
signals were appeared at δ 11.3, 18.7, 19.3, 14.1, 22.8 and 22.7 (Figs.
S1–S3), whereas the signals due to trisubstituted olefinic group were
found at δ 122.6 and 139.7 (eCH]C<) in the 13C NMR spectrum. The
deshielded signal at δ 173.0 indicated the presence of ester carbonyl
functionality. The compound exhibited only one singlet methyl signal at
δ 0.68 corresponding to the angular methyl at C-18 unlike the mol-
luskan sterols reported elsewhere, bearing two singlet methyls at C-18
Table 1
NMR spectroscopic data of the lactonic disecosteroid (in CDCl3†) isolated from
B. spirata.
O
O
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25
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6a
1, 10: 8, 9-disecoergosta-8-en-A-homo-6a-oxa-1-one
C. No. 13C, type 1H NMR (mult, J in Hz)†† COSY HMBC
1 173.0, C – – –
2 34.1, CH2 2.28 (t, 6.9) H-3 C-1
3 24.3, CH2 1.61 (p, 5.43) H-4 C-1
4 29.1, CH2 1.29 (m) H-5 C-6
5 49.8, CH 1.80 (m) H-6, H-10 C-7
6 73.7, CH 4.61 (td, 5.0, 10.0) H-7 C-1, 8, 4
6a -O- – – –
7 38.2, CH2 2.32 (p, 5.5) H-8 C-14, 8, 6
8 122.6, CH 5.36 (t, 6.6) – C-15, 6
9 36.6, CH2 1.26 (t, 7.49) H-11 –
10 35.8, CH 1.30 (m) H-19 –
11 22.5, CH2 1.51 (t, 5.30) H-12 –
12 39.5, CH2 1.16 (m) – –
13 50.0, C – – –
14 139.7, C – – –
15 27.2, CH2 2.03 (t, 7.5) H-16 C-14
16 25.0, CH2 1.34 (dt, 2.9, 6.5) H-17 –
17 56.7, CH 0.99 (m) H-20 C-14
18 11.3, CH3 0.68 (s) – C-17, 14, 13, 12
19 18.7, CH3 0.92 (d, 6.5) – C-9, 5
20 36.2, CH 1.40 (m) H-21 –
21 19.3, CH3 1.02 (d, 5.4) – C-20,17
22 34.8, CH2 1.22 (m) – C-21, 24
23 32.0, CH2 1.28 (m) H-24 –
24 39.6, CH 1.58 (m) H-241, H-25 –
241 14.1, CH3 0.89 (d, 6.0) – C-24, 23
25 28.1, CH 1.45 (t, 6.7) H-26, H-27 –
26 22.8, CH3 0.86 (d, 7.0) – C-25, 27
27 22.7, CH3 0.87 (d, 6.5) – C-25, 26
Assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and
NOESY experiments.
† NMR spectra recorded using Bruker AVANCE III 500MHz (AV 500) spec-
trometers.
†† Values in ppm, multiplicity and coupling constants (J=Hz) are indicated
in parentheses.
K. Chakraborty et al. Steroids 143 (2019) 41–48
43
and C-19 positions [20]. Five methyl signals were appeared as doublets
at δ 0.92, 0.89, 0.86, 0.87, 1.02 and a singlet methyl was found at about
δ 0.68. The deshielded olefinic proton at δ 5.36 appeared as a triplet,
which was attached to a carbon with δ 122.6 (HSQC) (Fig. S5). Detailed
inspection of the 1H-1H COSY spectrum identified four different partial
structures labelled as A, B, C and D of the consecutive spin systems. The
fragmental structure, ‘A’ revealed connectivities between δ 2.28 (H-2)/
1.61 (H-3)/1.29 (H-4)/1.80 (H-5)/4.61 (H-6), δ 4.61 (H-6)/2.32 (H-7)/
5.36 (H-8), δ 1.80 (H-5)/1.30 (H-10)/0.92 (H-19) and δ 1.26 (H-9)/
1.51 (H-11)/1.16 (H-12), which were apparent in the fragmented ‘B-C’
ring of the steroid framework (Figs. 1, S4). The spin system between the
protons, δ 2.03 (H-15)/1.34 (H-16)/0.99 (H-17)/1.40 (H-20)/1.02 (H-
21) appropriately attributed the ring ‘D’. The fragmental structure D,
which enclosed the part of the side chain was established by the cross-
peaks connecting between the protons δ 1.28 (H-23)/1.58 (H-24)/0.89
(H-241) and δ 1.58 (H-24)/1.45 (H-25)/0.86 (H-26), 0.87(H-27). The
presence of a hexanolactone ring and its adherence to a cyclodecene
ring were substantiated by the hetero-nuclear connections from δ 4.61
(H-6) to the carbonyl peak at δ 173.0 (C-1); δ 1.29 (H-4), 5.36 (H-8),
2.32 (H-7) that were abridged to the carbon at δ 73.7 (C-6), δ 4.61 (H-6)
to δ 29.1 (C-4) and 122.6 (C-8). The structural fragments, ‘A’ and ‘B’
were connected by the HMBC cross-peaks between δ 0.92 (H-19) and δ
36.6 (C-9) (Figs. 1, S6). The structural fragments, ‘B’ and ‘C’ were linked
via a quaternary carbon atom at δ 139.7 (C-14) due to the HMBC
correlations from δ 2.03 (H-15), 0.99 (H-17) and 2.32 (H-7) to δ 139.7
(C-14). The presence of the intact angular methyl group at the bridge
head between the cyclodecene moiety and the cylcopentane ring was
suggested by the cross-relation from δ 0.68 (H-18) to δ 39.5 (C-12),
50.0 (C-13), 139.7 (C-14) and 56.7 (C-17). The HMBC cross-peaks from
δ 0.89 (H-241) to δ 39.6 (C-24), 32.0 (C-23); δ 1.22 (H-22) to δ 39.6 (C-
24), 19.3 (C-21); δ 1.02 (H-21) to δ 36.2 (C-20), 56.7 (C-17) appro-
priately revealed the disposition of the carbon atoms in the side chain.
Thus, the basic skeleton of titled compound was found to be an er-
gostane with lactonic functionality in the ‘A’ ring along with bond
cleavages in the ‘A-B’ rings, whereas the nomenclature of the studied
steroid was ascertained by the previous literature reports [8]. The re-
lative stereochemistry of the chiral centers was assessed by the NOE
experiments (Figs. 1, S7). The NOE cross-peaks between δ 1.80 (H-5)
and 4.61 (H-6); δ 1.30 (H-10) and δ 1.80 (H-5) suggested their close
proximities, and were aligned in the same plane of symmetry, hence
subjectively fixed as α-oriented. Other NOE correlations between δ 0.68
(H-18) and 1.40 (H-20) in the compound described their same plane of
symmetry, and oppositely oriented to α-protons, thus the H-18 and H-
20 positions were fixed as β-oriented. The absence of absorption bands
in the region around 3500 cm−1 ascertained the lack of hydroxyl
functionality in the compound. The infrared absorption bands at
2924–2856 cm−1 were indicative of strong alkyl stretching vibrations
(CeH stretch), and the presence of ester functional groups was sug-
gested by the intense infrared band at 1745 cm−1. The molecular ion
peak of the isolated compound was observed at m/z 416 (Figs. S8–S9).
The presence of the prominent fragment ions at m/z 127 (d) and 289
[M-127] + suggested the presence of a saturated C9H20 hydrocarbon
side chain. Furthermore, the fragment ion at m/z 289 (c) underwent a
two bond cleavage eliminating an ethylene molecule and gave rise to a
peak at m/z 261 (e), which might have disintegrated into the fragment
ions at m/z 181 (f) and 233 (j). The mass fragmentation pathways at-
tributed the base peak at m/z 67 (i). It is of note that the carbon atoms
of the disecosteroid were numbered as numbering pattern of the se-
costeroids, and was dependent on the precursor sterol [21,22]. There-
fore, in the titled compound, though the 8, 9 and 1, 10 bonds were
cleaved, the sequences of the numbers have been maintained as in the
hypothesized ergosterol precursor.
3.3. Anti-carbolytic enzyme, anti-inflammatory and antioxidant activities
The greater carbolytic enzyme inhibition potentials of lactonic dis-
ecosteroid, isolated from B. spirata against α-amylase and α-glucosidase
enzymes were described by the lower IC50 values of 0.40 and 0.54mg/
mL, respectively (Table 2). The anti-5-lipoxidase activity of the titled
compound (IC50 0.82mg/mL) was found to be significantly greater
compared to the standard, ibuprofen (IC50 0.95mg/mL; p < 0.05). The
Fig. 1. (A) Representative shell-on samples of marine buccinid gastropod
Babylonia spirata. (B) 1H-1H COSY (bold face bonds), selected HMBC (red co-
lored single barbed arrows), and (C) NOESY (double headed colored arrows)
correlations of 1, 10: 8, 9-disecoergosta-8-en-A-homo-6a-oxa-1-one isolated
from the buccinid gastropod B. spirata.
Table 2
In vitro antioxidant, anti-inflammatory and anti-carbolytic activities of lactonic disecosteroid isolated from B. spirata.
Test compounds Antioxidant activity† Anti-inflammatory activity† Anti-carbolytic activity†
DPPH scavenging ABTS+ scavenging Fe2+ chelating 5-LOX inhibition α-amylase inhibition α-glucosidase inhibition
Lactonic disecosteroid 0.30a ± 0.02 0.37a ± 0.01 0.32a ± 0.01 0.82a ± 0.02 0.40a ± 0.03 0.54a ± 0.01
Standard‡ 0.60bT ± 0.02 0.73bT ± 0.02 0.26aC ± 0.02 0.95bI ± 0.02 0.28bA ± 0.01 0.31bA ± 0.02
The samples were analyzed in triplicate (n=3) and expressed as mean ± standard deviation.
Means followed by different superscripts (a-b) in a single column indicated significant differences (p < 0.05).
† The bioactivities were expressed as IC50 values (mg/mL).
‡ The standard used for antioxidant activity assays was α-tocopherol (T, indicated as superscript along with the value) and curcumin (C, indicated as superscript
along with the value), whereas those used for anti-inflammatory and anti-carbolytic assays were ibuprofen and acarbose (indicated as superscript I and A, re-
spectively), respectively.
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studied disecosteroid displayed significantly greater ABTS+ and DPPH
inhibitory potentials (IC50 0.37 and 0.30mg/mL, respectively) when
compared to the standard, α-tocopherol (IC50 0.73 and 0.60mg/mL,
respectively) (p < 0.05). The ferrous ion chelating ability of degraded
steroid was found to be comparable (IC50 0.32mg/mL) to that exhibited
by the standard, curcumin (IC50 0.26mg/mL).
The bioactive potencies of titled degraded steroid were correlated with
its structural parameters, such as steric and polarizability (Pl) factors. The
lower steric bulkiness as calculated by molar refractivity
{(MR=126.95 cm3/mol), molar volume (MV=431.5 cm3) and parachor
(Pr=1054.6 cm3)} might support the greater antioxidant functionalities
of the degraded steroid derivative when compared to α-tocopherol
(MR=135.06 cm3/mol; MV=462.70 cm3; Pr=1123.0 cm3). Notably,
the higher electronic properties of the compound that determined the
factor of polarizability, Pl (50.33) when compared to anti-inflammatory,
ibuprofen (Pl 24.09) supported its greater bioactive potencies over syn-
thetic compounds [23].
The greater DPPH and ABTS+ free radical inhibitory activities of
disecosteroid principally spelt its primary antioxidant potentials,
whereas metal ion (Fe2+) chelating activity could appropriately de-
scribe its secondary antioxidant properties. The proposed antioxidant
mechanism of the compound was described in Fig. S10. It might be
possible that the compound, 1, 10: 8, 9-disecoergosta-8-en-A-homo-6a-
oxa-1-one could easily donate a proton radical (from H-6 position)
through the hydrogen atom transfer (HAT) mechanism to the free ra-
dicals (hypothetically designated as R% in Fig. S10) to stabilize the
latter. The tertiary radical intermediate (with an unpaired electron at C-
6) of the studied lactonic disecosteroid from B. spirata could easily form
a stable conjugated structure of dodecahydro-2H-cyclopenta[7,8]cy-
clodeca[1,2-b]oxepin-2-one moiety of 1, 10: 8, 9-disecoergosta-6, 8-
dien-A-homo-6a-oxa-1-one by transferring the second proton radical
from H-7 to the free radical. Therefore, one mole of the studied com-
pound could potentially quench two equivalent moles of free radicals.
Thus, the potential DPPH (IC50 0.30mg/mL) and ABTS+ (IC50 0.37mg/
mL) radical scavenging activities of the studied disecosteroid could be
corroborated, and that the compound might be classified as a primary
antioxidant. Likewise, the secondary antioxidant potential of the dis-
ecosteroid was explained on the basis of its effective chelation with pro-
oxidant or catalyst metal ions, which could be related with its potential
Fe2+ chelating activity (IC50 0.32mg/mL). Thus, the studied molecule
was found to posses the characteristics of both radical-deactivating and
preventive antioxidants [24]. Notably, the titled lactonic disecosteroid
isolated from B. spirata was found to comprise of bioactive lactone
functionalities along with the olefinic groups, which might increase its
electronic properties. These functionalities would lead to the effective
transfer of protons for the quenching of free radicals in the biological
system. The carboxylate group in the studied compound might function
as the reaction center, which can easily donate hydrogens to neutralize
the highly reactive free radicals through the hydrogen atom transfer
(HAT) mechanism.
3.4. In silico molecular docking studies
The molecular docking analyses of lactonic disecosteroid against
inflammatory enzyme, 5-LOX and carbolytic enzymes α-amylase were
individually performed, and their RMSD factors were tabulated. The
binding energy, docking score, number of hydrogen bonds and hy-
drogen-bonded amino acids, inhibition constant, torsional free energy
and intermolecular energy variables among the compound along with
the active sites of 5-LOX and α-amylase enzymes were tabulated
(Table 3). The lowest binding energy and docking score of degraded
sterol against inflammatory 5-LOX enzyme were obtained through the
in silico molecular docking studies attributing its greater enzyme in-
hibitory potencies against inducible 5-LOX isoform, which were found
to be −4.14 and −4.95 kcal/mol, respectively in that order. Also, the
torsional free energy (0.89 kcal/mol) and intermolecular energy
(−4.96 kcal/mol) were deduced to be lesser for degraded sterol. The in
silico molecular docking analyses demonstrated the presence of one
hydrogen-bonded amino residue in the active binding site of 5-LOX
enzyme, which was found to be GLN282 with a hydrogen bond distance
of 2.943 Å (Fig. 2). The commercial standard, ibuprofen also exhibited
one hydrogen bond with an amino acyl residue of ILE330 with a hy-
drogen bond distance of 3.002 Å (Fig. S11) when compared to the
lactonic disecosteroid from B. spirata with one hydrogen bond. There-
fore, it was confirmed that the degraded steroid and ibuprofen were
bound to the amino acyl residues of GLN282 and ILE330 at the binding
sites of 5-LOX enzyme. However, the molecular docking factors suitably
proposed that the degraded sterol displayed closer molecular interac-
tions towards 5-LOX enzyme with least binding energy (-4.14 kcal/mol)
compared to ibuprofen with its greater binding energy of −3.44 kcal/
mol and greater docking score of −3.51 kcal/mol. These molecular
docking parameters of degraded steroid was appropriately corroborated
with their greater enzyme inhibition potential against 5-LOX (IC50
0.82mg/mL) (Table 2) than that exhibited by ibuprofen (IC50 0.95mg/
mL). Thus, the degraded steroid derived from B. spirata was found to
effectively inhibit pro-inflammatory enzyme, 5-LOX leading to the re-
tardation of the formation of inflammatory leukotrienes (LT). More-
over, the greater electronic parameter as determined by the factor of
polarizability (Pl 50.33) appropriately signified its greater electronic-
rich centers that could effectively interact with the binding site of 5-
LOX enzyme leading to the formation of stronger hydrogen bonds with
amino acyl residue when compared to ibuprofen with lowest polariz-
ability factor (Pl 24.09). Hence, the studied lactonic disecosteroid ex-
hibited effective hydrogen bonding simulations with the amino acyl
functionalities than those exhibited by ibuprofen. These results were
comparable with the 5-LOX inhibitory activity of degraded sterol over
those displayed by ibuprofen.
The molecular docking interactions of the studied degraded sterol
with α-amylase suggested its greater anti-carbolytic pluralities. It
showed minimum binding energy and docking score, which were found
to be −9.76 and −10.77 kcal/mol, respectively. The lowest inhibition
Table 3
Number of hydrogen bonds (H-bonds), hydrogen bonded (H-bonded) amino acid residue, binding energy, docking score, inhibition constant, intermolecular energy
and torsional free energy between lactonic disecosteroid and the active sites of 5-LOX and α-amylase.
Ligand †No. of H-
bonds
‡H-bonded amino
acid residues
††Binding energy
(kcal/mol)
††Docking score
(kcal/mol)
††Inhibition constant,
Ki (µM)
††Intermolecular energy
(kcal/mol)
††Torsional free energy
(kcal/mol)
5-LOX
Lactonic disecosteroid 1 GLN 282.A −4.14 −4.95 922.08 −4.96 0.89
α-amylase
Lactonic disecosteroid 2 GLU 233.A
ILE 235.A
−9.76 −10.77 0.07 −10.65 0.89
† Molecular docking simulations were carried out using Autodock 4.0 software tool.
‡ Hydrogen bonding interactions between the ligand and the protein complexes.
†† Values were evaluated from the calculations based on the energy minimization.
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constant, Ki of 0.07 µM confirmed the greater inhibitory activity of
degraded sterol against α-amylase. Also, the lesser torsional free energy
(0.89 kcal/mol) and intermolecular energy (−10.65 kcal/mol) appro-
priately supported its greater α-amylase inhibitory potential. The iso-
lated disecosteroid induced two hydrogen bonding interactions with
GLU233 and ILE235 residues with the bond distances of 2.531 Å and
3.234 Å, respectively, in the docking studies (Fig. 3). The oxygen atom
{eC(]O)eOe} in the ester carbonyl of the seven membered lactone
ring moiety in the degraded sterol underwent hydrogen bonding in-
teractions with the active sites of the enzyme amino acid residues. Thus,
the greater number of hydrogen bonds in the active site of α-amylase,
along with lower binding energy, docking score and inhibition constant
of the degraded sterol might be correlated with its greater in vitro
carbolytic enzyme inhibition potential (IC50 0.40mg/mL).
3.5. Biogenic origin of the lactonic disecosteroid isolated from B. spirata
Steroid chemistries of compounds constitute as the most common
secondary metabolites from marine resources with greater bioactive
potential [25–28]. Among these, secosteroids and lactonic steroids were
formed through the bond degradation in any one of the tetracyclic core,
which represented a minor class family [4,23]. A biogenic pathway
leading to the formation of lactonic disecosteroids was previously de-
scribed [8]. Unlike usual sterols, the A ring has been modified to a
lactonic functionality, which might be due to the adaptation against the
stressful environmental conditions. The A ring of the studied lactonic
disecosteroid from B. spirata has been oxidized and appeared to un-
dergo bond cleavage to result in its lactonization. Due to the presence of
an extra methyl group at C-24 position of the side chain, we have
Fig. 2. Closer view of molecular binding interactions
of the lactonic disecosteroid in the catalytic site of
(A–C) pro-inflammatory 5-lipoxidase as deduced
from the molecular docking simulation experiment.
The molecular docking analysis of the ligand (lac-
tonic disecosteroid) and 5-LOX showed one hydrogen
bond (displayed as an orange-colored line with
amino acyl residue of GLN282 with a bond distance of
2.943 Å) in the active binding site.
Fig. 3. Closer view of molecular binding interac-
tions of the lactonic disecosteroid in the catalytic
site of (A–C) the carbolytic enzyme α-amylase as
deduced from the molecular docking simulation
experiment. The molecular docking analysis of li-
gand (lactonic disecosteroid) showed two hydrogen
bonds (displayed as orange-colored lines with amino
acyl residues of GLU233 and ILE235 with bond dis-
tances of 2.531 Å and 3.234 Å, respectively) in the
active binding site.
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presumed that the precursor for a reasonable biogenic pathway of the
isolated disecosteroid might be ergosterol (a), which on hydrogenation
could yield 22, 23-dihydroergosterol (b). The epoxidation of latter at
C5-C6 position by the epoxidase could possibly lead to the formation of
unstable ergosterol epoxide, called as 5, 6-epoxy-22, 23-dihy-
droergosterol (c). The epoxide might have opened in a trans diaxial
fashion placing the hydroxyl at C-6 position (d) with minimal steric
strain. The oxidation of latter (d) resulted in the bond cleavage at C1-
C10 in the A ring of ergosterol, and an unstable aldehyde intermediate
was formed (e) [29]. The latter on further oxidation yielded an acid
functionality at the cleaved end of the A ring (f). The condensation of
acid at C1 and alcohol at C5 with the elimination of water molecule
could result in the formation of a lactonized intermediate bearing 4, 6-
dihydroxy-6-methyl-hexahydrobenzo[b]oxepin-2(9aH)-one skeleton
(g) [20]. The latter upon elimination of the hydroxyl groups at C-3 and
C-10 positions resulted in the formation of a substituted intermediate
named as 6-methyl-hexahydrobenzo[b]oxepin-2(9aH)-one (h), which
appeared to undergo isomerase-catalyzed double bond shift from C7-C8
position to C8-C14 (i). The subsequent bond cleavage at C8-C9 position
proposed the formation of studied lactonic secoergostane, named as 1,
10: 8, 9-disecoergosta-8-en-A-homo-6a-oxa-1-one (j) (Fig. 4).
The lactonic disecosteroid isolated from the EtOAc-MeOH extract of B.
spirata was found to possess potential anti-radical, anti-carbolytic, and
anti-inflammatory activities due to its characteristic structural features
including olefinic and carbonyl functionalities. It is of note that the
pharmacological properties of the C-28 secosteroids with δ- or γ-lactone
moieties were characterized in a previous report of literature [30].
4. Conclusions
Bioactivity-guided chromatographic fractionation of the ethyl
acetate:methanol extract of the buccinid gastropod, B. spirata afforded a
lactonic steroid with unprecedented disecoergostane framework, which
was characterized as 1, 10: 8, 9-disecoergosta-8-en-A-homo-6a-oxa-1-
one with underlying antioxidative, anti-carbolytic and anti-in-
flammatory activities. The titled compound could be considered as
novel pharmacophore lead that has significantly greater antioxidant
activities, as evidenced by its greater DPPH and ABTS+ (IC50
0.30–0.37mg/mL) radical scavenging properties than the commercial
antioxidant α-tocopherol (IC50 > 0.50mg/mL) and superior 5-lipox-
idase inhibition activity (IC50 0.82mg/mL) than the non-steroidal anti-
inflammatory drug, ibuprofen (IC50 0.95mg/mL). The target bioactiv-
ities of the studied lactonic disecosteroid were primarily dictated by the
greater polarizability parameters coupled with lesser steric factors. The
results of docking investigation also suggested the lower binding en-
ergies and docking scores of disecosteroids along with strong hydrogen
bonding interactions with the amino acid residues of 5-lipoxidase and
α-amylase enzymes, which were correlated with its in vitro biological
activities. These results appropriately suggested that the disecosteroid
could be subjected to further biomedical investigation so as to be used
as natural antioxidant, anti-carbolytic and anti-inflammatory lead in
pharmaceutical and food applications.
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